BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to H1650 cell line is 38
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay and SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1739 | 23009336 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.1135 | 29702194 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs | NA | 0.48 | 0.1135 | 21124918 |
| BMI1 | 1066 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Dexamethasone+Pemetrexed | FACs followed by SFA | NA | 0.48 | 0.1135 | 29753869 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 1 | 29702194 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by IHC staining and SFA | NA | 0.48 | 1 | 21124918 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | RT-PCR and FACs followed by SFA | NA | 0.48 | 1 | 28819374 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.48 | 1 | 30480362 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Dexamethasone+Pemetrexed | FACs followed by SFA | NA | 0.48 | 1 | 29753869 |
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.48 | 1 | 24091605 |
| MCL1 | 6943 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0032 | 23418490 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.6448 | 29702194 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by IF staining | NA | 0.48 | 0.6448 | 21124918 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and qPCR | NA | 0.48 | 0.6448 | 24091605 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | Western Blotting | NA | 0.48 | 0.6448 | 34803670 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.48 | 0.6448 | 30480362 |
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Dexamethasone+Pemetrexed | FACs followed by SFA | NA | 0.48 | 0.6448 | 29753869 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and Western Blotting | NA | 0.48 | 0.7582 | 29702194 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and RT-PCR | NA | 0.48 | 0.7582 | 25678473 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and FACs | NA | 0.48 | 0.7582 | 26299367 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | Western Blotting | NA | 0.48 | 0.7582 | 34803670 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.48 | 0.7582 | 30480362 |
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Dexamethasone+Pemetrexed | FACs followed by SFA | NA | 0.48 | 0.7582 | 29753869 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and RT-PCR | NA | 0.32 | 0.211 | 25678473 |
| EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and FACs | NA | 0.32 | 0.211 | 26299367 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and qPCR | NA | 0.32 | 0.5461 | 24091605 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SFA followed by qPCR and FACs | NA | 0.32 | 0.5461 | 26299367 |
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.32 | 0.5461 | 30480362 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and qPCR | NA | 0.32 | 0.5695 | 24091605 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay followed by SFA and Western Blotting | NA | 0.32 | 0.5695 | 30831275 |
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.32 | 0.5695 | 30480362 |
| CD24 | 1645 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | Erlotinib | qRT-PCR | NA | 0.2 | 0.456 | 30480362 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.12 | 0.684 | 24091605 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs followed by SFA and Tumorigenicity assay | NA | 0.12 | 0.684 | 28819374 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay and ALDEFLUOR assay followed by SFA and Tumorigenicity assay | NA | 0.12 | 0.684 | 23418490 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay followed by ALDEFLUOR assay and SFA | NA | 0.12 | 0.684 | 23418490 |
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | SP assay followed by SFA and ALDEFLUOR assay | NA | 0.12 | 0.684 | 26297432 |
| CD34 | 1662 | LTM | Non Small Cell Lung Cancer | Bronchioalveolar Carcinoma | H1650 | NA | FACs | NA | 0.12 | 0.0053 | 21124918 |